Last reviewed · How we verify
Tongguan capsule — Competitive Intelligence Brief
marketed
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Tongguan capsule (Tongguan capsule) — Guangdong Provincial Hospital of Traditional Chinese Medicine. Tongguan capsule is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to treat cardiovascular and related conditions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tongguan capsule TARGET | Tongguan capsule | Guangdong Provincial Hospital of Traditional Chinese Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tongguan capsule CI watch — RSS
- Tongguan capsule CI watch — Atom
- Tongguan capsule CI watch — JSON
- Tongguan capsule alone — RSS
Cite this brief
Drug Landscape (2026). Tongguan capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/tongguan-capsule. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing